Biopharma's 10 highest-paid CSOs and CMOs in 2025: Lilly's Dan Skovronsky led at $17.8M, with nine others topping $10M.
Biopharma’s top scientists and doctors don’t make nearly as much as CEOs, but some still took in eight-figure pay packages in 2025.
As part of …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Healthcare costs poised to jump 9% in 2027 as health plans blame AI adoption, drug prices
Health Care Up Amid Multibillion Dollar Oncology Deals - Health Care Roundup
Prometheus raises $12 billion in capital for artificial engineers
AI drug discovery leaders warn U.S. health funding cuts risk falling behind global rivals | Fortune
With ADA in the books, analyst says Lilly is ‘widening its lead’ in the obesity race
AI medical advice changes care decisions of most users: survey
The typical worker in biopharma made $116,648 in 2025, according to an Endpoints News pay analysis, earning about 30% more than…
Endpoints launches its annual biopharma pay project; Andrew Dunn and Drew Armstrong break down CEO compensation live on June 9,…
We hope 2026 is calmer after tariffs, public health chaos, and the cancellation of billions of research funding and health…
As the health insurance industry continues to face significant headwinds and challenges, the CEOs of major firms largely stayed…
Twelve biopharma execs collected nearly $1B in golden parachutes from 2025–26 M&A deals, led by Cidara's Jeffrey Stein ($221M)…
Biopharma sales trended upward in the first quarter of this year as eight of the industry’s top-25 companies achieved…
